entity

SARM1, NMNAT2

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SARM1, NMNAT2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
neurodegenerationpromoted: SARM1-Mediated NAD+ Depletion as Terminal Executor of MCT1-Dependent Axon Degenerationdisease0.61

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
SARM1-Mediated NAD+ Depletion as Terminal Executor of MCT1-D 0.698 neurodegeneration What is the molecular mechanism by which

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the molecular mechanism by which oligodendroglial MCT1 disruption causes

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.698

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The study shows that MCT1 disruption leads to axon degeneration and neuron death

closed · Rounds: 4 · Score: 0.78 · 2026-04-14

The study shows that MCT1 disruption leads to axon degeneration and neuron death

closed · Rounds: 4 · Score: 0.82 · 2026-04-13

Related Research

Hypotheses and analyses mentioning SARM1, NMNAT2 in their description or question text

No additional research found